ATLASGlobal X Genomics & Biotechnology ETF (GNOM): outlook, holdings and fees
Global X Genomics & Biotechnology ETF (GNOM) is an exchange-traded fund and is managed by Global X Funds. The expense ratio is 0.47% and the yield is 0.89%. The ten largest holdings are 55% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on GNOM
| Last price | $67.52 (-3.0%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 49% |
| Likely 1-month range (50%) | $62.64 – $72.53 |
| Normal 1-day range (±1σ) | ±2.5% |
| Distribution yield | 0.89% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
GNOM fund facts
| Issuer | Global X Funds |
|---|---|
| Theme | Technology & innovation |
| Assets under management | $97.8M |
| Expense ratio | 0.47% |
| Number of holdings | 49 |
| Portfolio turnover | 16% |
| Inception | Apr 5, 2019 |
| Exchange | NASDAQ |
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
GNOM top holdings
| Holding | Sector | Weight |
|---|---|---|
| Moderna Inc MRNA | Healthcare | 11.33% |
| Twist Bioscience Corp TWST | Healthcare | 6.86% |
| 10X Genomics Inc TXG | Healthcare | 6.76% |
| Illumina Inc ILMN | Healthcare | 5.80% |
| Natera Inc NTRA | Healthcare | 5.18% |
| Guardant Health Inc GH | Healthcare | 5.33% |
| Genscript Biotech Corp 1548 | Healthcare | 4.48% |
| Bio-Techne Corp TECH | Healthcare | 3.29% |
| Vertex Pharmaceuticals Inc VRTX | Healthcare | 3.18% |
| Qiagen NV QGEN | Healthcare | 3.24% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
GNOM sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 99.7% |
| Technology | 0.3% |
By region: North America 95.3%, Europe Developed 3.6%, United Kingdom 1.2%.
GNOM returns and risk
| Year to date | +43.6% |
|---|---|
| 1 year | +58.9% |
| 3 years (annualised) | +19.5% |
| 5 years (annualised) | -4.7% |
| 10 years (annualised) | 0.0% |
| Volatility (3 years) | 31.9% |
| Sharpe ratio (3 years) | 0.60 |
Past returns do not guarantee future results.
GNOM: frequently asked questions
What does GNOM invest in?
Global X Genomics & Biotechnology ETF invests in a portfolio of securities. Its largest holdings are Moderna Inc (11.3%), Twist Bioscience Corp (6.9%), 10X Genomics Inc (6.8%), Illumina Inc (5.8%), Natera Inc (5.2%).
What is the GNOM expense ratio?
0.47% a year: about $47.00 for every $10,000 invested.
What is the GNOM dividend yield?
0.89%. ATLAS does not hold the exact distribution dates for ETFs.
Will GNOM go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 49%, with a likely range (50%) of $62.64 to $72.53 from $67.52 today. It is a probability, not a prediction.
How has GNOM performed?
Year to date +43.6%, one year +58.9%, three years +19.5% a year, five years -4.7% a year. Past returns do not guarantee future results.
Similar ETFs: Technology & innovation
- Vanguard Information Technology ETF (VGT)
- State Street Technology Select Sector SPDR ETF (XLK)
- iShares U.S. Technology ETF (IYW)
- Fidelity MSCI Information Technology Index ETF (FTEC)
- First Trust Nasdaq Cybersecurity ETF (CIBR)
- iShares Expanded Tech-Software Sector ETF (IGV)
- iShares A.I. Innovation and Tech Active ETF (BAI)
- iShares Expanded Tech Sector ETF (IGM)
Educational information, not investment advice. Disclaimer